On April 4th, INL – International Iberian Nanotechnology Laboratory, in collaboration with the BIOCELLPHE project, is set to host an Open Session focused on pioneering advancements in single-cell analysis.

This exclusive event presents a platform to delve into the challenges and opportunities within the field of single-cell analysis. Participants will have the opportunity to engage in discussions with leading experts and researchers, exploring the potential impact of these advancements on personalized oncology.

INL’s partnership in the BIOCELLPHE project underscores its commitment to driving innovation and fostering collaboration at the forefront of nanotechnology research. By hosting this Open Session, INL aims to facilitate knowledge exchange and stimulate dialogue among stakeholders invested in the future of healthcare and diagnostics.

Don’t miss this opportunity to be part of a transformative discussion on the cutting-edge developments in single-cell analysis for personalized oncology. Join us at INL on April 4th and be a part of shaping the future of healthcare.

BIOCELLPHE, a project funded by the European Union’s Horizon 2020 FET-OPEN programme under Grant Agreement No #965018, aims to revolutionize the identification of proteins as diagnostic biomarkers at the single-cell level, boasting unparalleled sensitivity, multiplexing capabilities, and portability.

Registration for the event is now open. To secure your spot and access the agenda, please register below.